A new trading day began on Tuesday, with LAVA Therapeutics NV (NASDAQ: LVTX) stock price down -3.94% from the previous day of trading, before settling in for the closing price of $0.99. LVTX’s price has ranged from $0.88 to $6.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 61.16%. Meanwhile, its annual earnings per share averaged 27.07%. With a float of $14.17 million, this company’s outstanding shares have now reached $26.30 million.
Let’s determine the extent of company efficiency that accounts for 37 employees. In terms of profitability, gross margin is 94.8%, operating margin of -381.76%, and the pretax margin is -372.12%.
LAVA Therapeutics NV (LVTX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of LAVA Therapeutics NV is 46.12%, while institutional ownership is 14.32%.
LAVA Therapeutics NV (LVTX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.07% per share during the next fiscal year.
LAVA Therapeutics NV (NASDAQ: LVTX) Trading Performance Indicators
Here are LAVA Therapeutics NV’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.35 in one year’s time.
Technical Analysis of LAVA Therapeutics NV (LVTX)
Looking closely at LAVA Therapeutics NV (NASDAQ: LVTX), its last 5-days average volume was 0.14 million, which is a drop from its year-to-date volume of 0.51 million. As of the previous 9 days, the stock’s Stochastic %D was 44.17%. Additionally, its Average True Range was 0.12.
During the past 100 days, LAVA Therapeutics NV’s (LVTX) raw stochastic average was set at 5.80%, which indicates a significant decrease from 12.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 84.59% in the past 14 days, which was higher than the 82.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5474, while its 200-day Moving Average is $2.0751. However, in the short run, LAVA Therapeutics NV’s stock first resistance to watch stands at $0.9840. Second resistance stands at $1.0170. The third major resistance level sits at $1.0340. If the price goes on to break the first support level at $0.9340, it is likely to go to the next support level at $0.9170. Now, if the price goes above the second support level, the third support stands at $0.8840.
LAVA Therapeutics NV (NASDAQ: LVTX) Key Stats
With a market capitalization of 24.02 million, the company has a total of 25,350K Shares Outstanding. Currently, annual sales are 6,770 K while annual income is -41,970 K. The company’s previous quarter sales were 0 K while its latest quarter income was -8,300 K.